Objectif
EBiSC is designed to address the increasing demand by iPSC researchers for quality-controlled, disease-relevant research grade iPSC lines, data and cell services. Its goal is to demonstrate an operational banking and distribution service of iPSC lines after 3 years and to establish subsequently for Europe a centralised, not-for-profit bank providing all qualified users with access to scalable, cost-efficient and customised products. The EBiSC Consortium including EFPIA partners boasts the leadership, scientific expertise, facilities, networks and experience to achieve these goals and, being representative of all stakeholders from tissue donors to clinical and academic iPSC researchers and industrial users, to respond appropriately to advances in science and society. Led by Pfizer Ltd and managed by Roslin Cells, the Consortium comprises 8 active participant iPSC Centres with clinical and patient networks, a global leader in industrial iPSC supply, international experts in iPSC science, biobanking, bioengineering and regenerative medicine, and scholars in law and ethics. The main facility will be at the Babraham Research Campus (Cambridge, UK) and will undertake cell expansion, QC and characterisation. The European Cell Culture Collection (ECACC) of Public Health England (Department of Health, UK) will coordinate cell line distribution. The Fraunhofer IBMT (Saarbrücken, Germany) will provide comprehensive operational back up. EBiSC’s capacity will be 10,000 cell lines; it will eventually process over 1,000 lines in annual sales. In a phased business strategy EBiSC will hot-start distribution of lines contributed by iPSC Centres in 2014, lines collected based on specified user demand, will reach full scale operations in 2016, and with extended funding will become self-sustaining as a not for profit banking operation by 2019. EBiSC will spearhead Europe in the international standardisation of iPSC banking by forging collaborative links with similar endeavours in the USA and Asia. Through market research, stakeholder engagement, incentives and training, EBiSC will promote wider participation and use, maximise the value of the research resource, and secure its longevity. EBiSC will promote iPSC technology and global iPSC banking, strengthen the competitiveness of European R&D, and enhance the health and wealth of nations.
Champ scientifique
Appel à propositions
IMI-JU-08-2012
Voir d’autres projets de cet appel
Régime de financement
JTI-CP-IMI - Joint Technology Initiatives - Collaborative Project (IMI)Coordinateur
2340 Beerse
Belgique
Voir sur la carte
Participants (28)
EH8 9YL Edinburgh
Voir sur la carte
Participation terminée
EH25 9PP Roslin, Midlothian
Voir sur la carte
80686 Munchen
Voir sur la carte
CB10 1SA SAFFRON WALDEN
Voir sur la carte
4057 Basel
Voir sur la carte
69117 Heidelberg
Voir sur la carte
10117 Berlin
Voir sur la carte
NE1 7RU Newcastle Upon Tyne
Voir sur la carte
50937 Koeln
Voir sur la carte
30167 Hannover
Voir sur la carte
1011 JV AMSTERDAM
Voir sur la carte
Participation terminée
22525 Hamburg
Voir sur la carte
WC1E 6BT London
Voir sur la carte
LS2 7UE Leeds
Voir sur la carte
2970 Hoersholm
Voir sur la carte
53127 Bonn
Voir sur la carte
CB2 1PH Cambridge
Voir sur la carte
75008 Paris
Voir sur la carte
28029 Madrid
Voir sur la carte
151 85 Sodertaelje
Voir sur la carte
2500 Valby
Voir sur la carte
2880 Bagsvaerd
Voir sur la carte
Participation terminée
1070 Bruxelles / Brussel
Voir sur la carte
CT13 9NJ Sandwich
Voir sur la carte
1070 Bruxelles / Brussel
Voir sur la carte
51373 Leverkusen
Voir sur la carte
EH25 9PP Roslin, Midlothian
Voir sur la carte
RG21 4FA Basingstoke
Voir sur la carte